Viewing Study NCT05513950


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2025-12-27 @ 8:56 PM
Study NCT ID: NCT05513950
Status: COMPLETED
Last Update Posted: 2025-08-14
First Post: 2022-08-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD).
Sponsor: Chiesi Farmaceutici S.p.A.
Organization: